Tanshinone IIA downregulates HMGB1 and TLR4 expression in a spinal nerve ligation model of neuropathic pain

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Ma, Yu Qing ^a   Chen, Yi Rong ^b   Leng, Yu Fang ^a   Wu, Zhi Wei ^c  

^a LANZHOU UNIVERSITY   (China)

^b GANSU PROVINCIAL HOSPITAL   (China)

^c GANSU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; TANSHINONE IIA; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HEAT; HYPERALGESIA; LATENT PERIOD; MALE; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PAIN THRESHOLD; PAW MECHANICAL WITHDRAWAL THRESHOLD; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SPINAL CORD; SPINAL NERVE LIGATION; WESTERN BLOTTING;

EID: 84904614305     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/639563     Document Type: Article

References (26)

1. Baron R., Peripheral neuropathic pain: from mechanisms to symptoms. Clinical Journal of Pain 2000 16 2 S12 S20 10.1097/00002508-200006001-00004 2-s2.0-0034040041 (Pubitemid 30395239)
2. Cao L., Tanga F. Y., DeLeo J. A., The contributing role of CD14 in toll-like receptor 4 dependent neuropathic pain. Neuroscience 2009 158 2 896 903 10.1016/j.neuroscience.2008.10.004 2-s2.0-58249083141
3. Janeway C. A. Jr., Medzhitov R., Innate immune recognition. Annual Review of Immunology 2002 20 197 216 10.1146/annurev.immunol.20.083001.084359 2-s2.0-0036212849 (Pubitemid 34293424)
4. Akira S., Uematsu S., Takeuchi O., Pathogen recognition and innate immunity. Cell 2006 124 4 783 801 10.1016/j.cell.2006.02.015 2-s2.0-32944464648 (Pubitemid 43261452)
5. Ren K., Torres R., Role of interleukin-1 β during pain and inflammation. Brain Research Reviews 2009 60 1 57 64 10.1016/j.brainresrev.2008. 12.020 2-s2.0-63749115547
6. Jiang W., Pisetsky D. S., The role of IFN-alpha; and nitric oxide in the release of HMGB1 by RAW 264.7 cells stimulated with polyinosinic-polycytidylic acid or lipopolysaccharide. Journal of Immunology 2006 177 5 3337 3343 10.4049/jimmunol.177.5.3337 2-s2.0-33747794011 (Pubitemid 44277853)
7. Sims G. P., Rowe D. C., Rietdijk S. T., Herbst R., Coyle A. J., HMGB1 and RAGE in inflammation and cancer. Annual Review of Immunology 2010 28 367 388 10.1146/annurev.immunol.021908.132603 2-s2.0-77952298772
8. Feldman P., Due M. R., Ripsch M. S., Khanna R., White F. A., The persistent release of HMGB1 contributes to tactile hyperalgesia in a rodent model of neuropathic pain. Journal of Neuroinflammation 2012 9 1, article 180 10.1186/1742-2094-9-180 2-s2.0-84868359842
9. Zimmermann M., Pathobiology of neuropathic pain. European Journal of Pharmacology 2001 429 1-3 23 37 10.1016/S0014-2999(01)01303-6 2-s2.0-0035840825 (Pubitemid 33043979)
10. Lyon R. M., Clarke S., Milligan D., Clegg G. R., Resuscitation feedback and targeted education improves quality of pre-hospital resuscitation in Scotland. Resuscitation 2012 83 1 70 75 10.1016/j.resuscitation.2011.07.016 2-s2.0-83555178543
11. Fan G., Gao X., Wang H., Zhu Y., Zhang J., Hu L., Su Y., Kang L., Zhang B., The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS. Journal of Steroid Biochemistry and Molecular Biology 2009 113 3-5 275 280 10.1016/j.jsbmb.2009.01.011 2-s2.0-61349154148
12. Yang R., Liu A., Ma X., Li L., Su D., Liu J., Sodium tanshinone IIA sulfonate protects cardiomyocytes against oxidative stress-mediated apoptosis through inhibiting JNK activation. Journal of Cardiovascular Pharmacology 2008 51 4 396 401 10.1097/FJC.0b013e3181671439 2-s2.0-42449089893 (Pubitemid 351572239)
13. Pang H., Han B., Yu T., Peng Z., The complex regulation of tanshinone IIA in rats with hypertension-induced left ventricular hypertrophy. PLoS ONE 2014 9 3 e92216
14. Wu H., Li Y., Wang Y., Xu D., Li C., Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis via modulating angiotensin-converting enzyme 2/angiotensin-(1-7) axis in rats. International Journal of Medical Sciences 2014 11 6 578 586 10.7150/ijms.8365
15. Yin X., Yin Y., Cao F., Chen Y., Peng Y., Hou W., Sun S., Luo Z., Tanshinone IIA attenuates the inflammatory response and apoptosis after traumatic injury of the spinal cord in adult rats. PLoS ONE 2012 7 6 e38381 10.1371/journal.pone.0038381 2-s2.0-84861740605
16. Kim S. H., Chung J. M., An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992 50 3 355 363 10.1016/0304-3959(92)90041-9 2-s2.0-0026727999
17. Dixon W. J., Efficient analysis of experimental-observations. Annual Review of Pharmacology and Toxicology 1980 20 4 441 462
18. Chaplan S. R., Bach F. W., Pogrel J. W., Chung J. M., Yaksh T. L., Quantitative assessment of tactile allodynia in the rat paw. Journal of Neuroscience Methods 1994 53 1 55 63 10.1016/0165-0270(94)90144-9 2-s2.0-0027933374 (Pubitemid 24238751)
19. Tong W., Wang W., Huang J., Ren N., Wu S., Li Y., Spinal high-mobility group box 1 contributes to mechanical allodynia in a rat model of bone cancer pain. Biochemical and Biophysical Research Communications 2010 395 4 572 576 10.1016/j.bbrc.2010.04.086 2-s2.0-77952102555
20. Shibasaki M., Sasaki M., Miura M., Mizukoshi K., Ueno H., Hashimoto S., Tanaka Y., Amaya F., Induction of high mobility group box-1 in dorsal root ganglion contributes to pain hypersensitivity after peripheral nerve injury. Pain 2010 149 3 514 521 10.1016/j.pain.2010.03.023 2-s2.0-77952100282
21. Nakamura Y., Morioka N., Abe H., Zhang F. F., Hisaoka-Nakashima K., Liu K., Nishibori M., Nakata Y., Neuropathic pain in rats with a partial sciatic nerve ligation is alleviated by intravenous injection of monoclonalantibody to high mobility group box-1. PLoS ONE 2013 8 8 e73640 10.1371/journal.pone.0073640 2-s2.0-84882609710
22. Maeda T., Ozaki M., Kobayashi Y., HMGB1 as a potential therapeutic target for neuropathic pain. Journal of Pharmacological Sciences 2013 123 4 301 305
23. Kawai T., Akira S., TLR signaling. Cell Death & Differentiation 2006 13 5 816 825 10.1038/sj.cdd.4401850 2-s2.0-33645960706
24. Christianson C. A., Dumlao D. S., Stokes J. A., Dennis E. A., Svensson C. I., Corr M., Yaksh T. L., Spinal TLR4 mediates the transition to a persistent mechanical hypersensitivity after the resolution of inflammation in serum-transferred arthritis. Pain 2011 152 12 2881 2891 10.1016/j.pain.2011.09. 020 2-s2.0-81055156707
25. Sorge R. E., LaCroix-Fralish M. L., Tuttle A. H., Sotocinal S. G., Austin J., Ritchie J., Chanda M. L., Graham A. C., Topham L., Beggs S., Salter M. W., Mogil J. S., Spinal cord toll-like receptor 4 mediates inflammatory and neuropathic hypersensitivity in male but not female mice. Journal of Neuroscience 2011 31 43 15450 15454 10.1523/JNEUROSCI.3859-11.2011 2-s2.0-80054947020
26. Lawrence S., Willmott L., Milligan E., Winch S., White B., Parker M., Autonomy versus futility? Barriers to good clinical practice in end-of-life care: a queensland case. Medical Journal of Australia 2012 196 6 404 405 10.5694/mja10.10969 2-s2.0-84861155777